Developer docs
API playgroundTry for free, no card

Search company profiles

ATLAS Biolabs

Full company profile

uuid002dptj

Namestring
ATLAS Biolabs
Legal namestring
Atlas Life Sciences GmbH
Company typeenum
Private
Founded yearint
2006
Descriptiontext

ATLAS Biolabs, operated by Atlas Life Sciences GmbH and headquartered in Berlin, is a molecular diagnostics infrastructure company that has operated for 20+ years in sequencing, array-based analysis, and bioinformatics. The company positions itself as the operational layer beneath modern molecular diagnostics, offering an integrated platform — Atlas OS — that combines digital order management, automated laboratory routing, wet-lab processing, and bioinformatics pipelines into a single end-to-end system. Service offerings include Next-Generation Sequencing (whole genome, whole exome, targeted panels, amplicons), Molecular Karyotyping (CytoScan-based CNV/LOH detection), Epigenomics & Methylation, Pharmacogenomics, and Proteomics & Multi-Omics.

The company serves enterprise customers across three primary verticals: global pharmaceutical companies (including Bayer, Boehringer Ingelheim, Novartis, and Sanofi), academic and university medicine (Charité Berlin, Max Planck Society), and clinical diagnostics laboratories. Its go-to-market combines a self-serve digital platform (Atlas Portal) for direct sample submission and order creation with a partner laboratory network (Life & Brain, MDI Limbach Berlin) coordinated by Atlas Operator, and is supported by a technology ecosystem relationship with Thermo Fisher Scientific. The company claims 2,000+ customers served and 100,000+ samples processed cumulatively.

Atlas generates revenue through service-based laboratory fees for molecular analysis work, with quote-based enterprise pricing rather than publicly disclosed rate cards. The business model is a hybrid of direct enterprise lab services and a platform-mediated, routed distribution model that leverages partner lab capacity. Headcount is reported at 11–50 employees, and the company is privately held with no disclosed venture capital, private equity, or parent company ownership in the source data. The CEO is Paul Froutan. No funding rounds, acquisitions, regulatory actions, patents, or certifications were disclosed in the available material.

Short descriptiontext

ATLAS Biolabs is a Berlin-based molecular diagnostics infrastructure company offering an integrated platform (Atlas OS) that combines digital order management, automated laboratory routing, wet-lab processing, and bioinformatics to serve global pharmaceutical, academic research, and clinical diagnostics customers with genomic and multi-omics analysis services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics services, next-generation sequencing, bioinformatics analysis, pharmacogenomics testing, genome analysis
Industry3 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Molecular Diagnostics Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Molecular Diagnostics Laboratory Services
TypeProfessional Services
Description

Atlas provides molecular analysis services including NGS, molecular karyotyping, epigenomics, pharmacogenomics, and proteomics. Revenue is generated through laboratory service fees charged to pharma, research, and clinical diagnostic customers. The platform routes orders to internal or partner laboratories under standardized operational protocols.

atlasbiolabs.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ATLAS Biolabs operates a molecular diagnostics infrastructure combining wet-lab processing, bioinformatics, and digital workflow software. The company provides next-generation sequencing, molecular karyotyping, epigenomics, pharmacogenomics, and proteomics services routed through the Atlas OS platform, which integrates digital order management, automated laboratory assignment, sequencing/array processing, and structured report delivery. Services are delivered to enterprise customers in pharmaceutical, clinical diagnostics, and academic research sectors under standardized operational protocols.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ATLAS Biolabs offers a unified platform-plus-modules architecture built around Atlas OS, an operational system for molecular diagnostics. The platform integrates multiple components: Atlas Portal (customer-facing interface for orders and results), Atlas Operator (automated routing), Atlas Lab (wet lab processing), and Atlas Bioinformatics (analysis and interpretation). These modules work together as an end-to-end operational system spanning sample intake, laboratory assignment, execution, review, and delivery. The service portfolio includes Next-Generation Sequencing (whole genome, exome, panels, amplicons), Molecular Karyotyping (CytoScan-based CNV/LOH detection), Epigenomics & Methylation profiling, Pharmacogenomics for medication optimization, and Proteomics & Multi-Omics. Atlas Protocol serves as a discovery platform for exploring diagnostic protocols.

Product and service9 records
1Atlas OS
CategoryPlatform
Description

Operational system layer beneath molecular diagnostics that integrates software, laboratory workflows, and structured data delivery into a single layer for intake, routing, analysis, and delivery across laboratories, clinics, and care networks.

2Atlas Portal
CategoryPlatform
Description

Customer-facing digital platform for sample intake, order creation, digital consent capture, sample metadata management, service selection, and structured result delivery. Reports are tracked, versioned, and available alongside the original order record.

3Atlas Protocol
CategoryPlatform
Description

Discovery platform for exploring and understanding Atlas Biolabs' diagnostic protocols and services.

4Next-Generation Sequencing (NGS)
CategoryLaboratory Service
Description

Whole genome, whole exome, targeted panels, and amplicon sequencing services run under standardized operational standards across established and emerging platforms, for pharma, research, and clinical diagnostics customers.

5Molecular Karyotyping
CategoryLaboratory Service
Description

CytoScan-based genome-wide copy number variation (CNV) and loss of heterozygosity (LOH) detection for molecular cytogenetic analysis.

6Epigenomics & Methylation
CategoryLaboratory Service
Description

Genome-wide and targeted methylation profiling services for epigenetic analysis.

7Pharmacogenomics (PGx)
CategoryLaboratory Service
Description

Preemptive pharmacogenomic profiling for medication optimization, enabling personalized drug selection based on genetic makeup.

8Proteomics & Multi-Omics
CategoryLaboratory Service
Description

Protein-level analysis integrated with genomic data for comprehensive multi-omics profiling.

9Bioinformatics Services
CategoryLaboratory Service
Description

Custom pipelines, variant calling, quality control, and interpretation services for molecular diagnostics results, preparing them for structured and auditable delivery.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Thermo Fisher Scientific is featured in Atlas's ecosystem as a selected relationship in diagnostics infrastructure. The partnership provides Atlas access to established laboratory technology platforms for molecular diagnostics operations.

Strategic tierCoreTypeTechnology or Integration
Description

Life & Brain is listed as a partner laboratory in Atlas's diagnostics infrastructure ecosystem. The partnership enables routing of orders to Life & Brain facilities based on capacity and capability requirements under standardized Atlas operational rules.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

MDI Limbach Berlin is featured in Atlas's ecosystem as a selected relationship in diagnostics infrastructure. As a partner laboratory, orders are routed to MDI Limbach based on optimal laboratory assignment criteria including capacity and turnaround time.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Korea-based global genomics services company providing NGS, Sanger sequencing, microarray, and bioinformatics to pharma, clinical, and research customers. Comparable across service mix, customer segments, and international delivery.

2CeGaT
TypeDirect peer
Description

Tübingen-based genomics and multi-omics services provider offering NGS, panels, and bioinformatics for pharma, research, and clinical customers. Closest direct peer to Atlas given German base, similar service portfolio, and overlapping pharma and academic customer base.

TypeBroad incumbent
Description

Global leader in sample preparation, molecular diagnostics assays, and bioinformatics (including the N-of-One acquired assets). Comparable at the bioinformatics and molecular diagnostics intersection, though QIAGEN is a much larger broad incumbent with its own assay portfolio.

TypeEmerging player
Description

India- and US-based genomics and molecular diagnostics services company focused on genetic testing, NGS panels, and pharmacogenomics. Comparable in molecular diagnostics services for clinical and research customers, though at a different scale and geographic focus.

TypeBroad incumbent
Description

One of the largest global genomics services organizations, with broad NGS, reproductive health, and clinical diagnostics offerings. Comparable in services but vastly larger scale and geographic footprint.

TypeDirect peer
Description

Leading global NGS services provider with whole genome, exome, transcriptomics, and epigenomics offerings for pharma and academic customers. Directly comparable on service catalog, customer segments, and global delivery model.

TypeEmerging player
Description

India-based company combining clinical genomics diagnostics, bioinformatics software, and pharma biomarker services. Comparable across multi-omics analytics and pharma services, though with a different geographic and customer mix.

TypeBroad incumbent
Description

US-based clinical oncology-focused molecular diagnostics and contract research services company. Comparable in clinical molecular diagnostics services and pharma CRO offerings, but at much larger scale and oncology-centric scope.

TypeBroad incumbent
Description

Atlas's named ecosystem partner and a global leader in sequencing instruments, NGS reagents, and clinical NGS services. Comparable at the molecular diagnostics infrastructure layer, though Thermo Fisher is a broad incumbent with much greater scale and instrument ownership.

TypeBroad incumbent
Description

Global genomics services arm of Eurofins Scientific, offering sequencing, genotyping, oligonucleotides, and bioinformatics at much larger scale. Comparable offering but as a much broader incumbent across many geographies and assay types.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ATLAS Biolabs

Molecular Diagnostics Servicesatlas-biolabs.com

ATLAS Biolabs is a Berlin-based molecular diagnostics infrastructure company offering an integrated platform (Atlas OS) that combines digital order management, automated laboratory routing, wet-lab processing, and bioinformatics to serve global pharmaceutical, academic research, and clinical diagnostics customers with genomic and multi-omics analysis services.

What ATLAS Biolabs does

ATLAS Biolabs, operated by Atlas Life Sciences GmbH and headquartered in Berlin, is a molecular diagnostics infrastructure company that has operated for 20+ years in sequencing, array-based analysis, and bioinformatics. The company positions itself as the operational layer beneath modern molecular diagnostics, offering an integrated platform — Atlas OS — that combines digital order management, automated laboratory routing, wet-lab processing, and bioinformatics pipelines into a single end-to-end system. Service offerings include Next-Generation Sequencing (whole genome, whole exome, targeted panels, amplicons), Molecular Karyotyping (CytoScan-based CNV/LOH detection), Epigenomics & Methylation, Pharmacogenomics, and Proteomics & Multi-Omics.

The company serves enterprise customers across three primary verticals: global pharmaceutical companies (including Bayer, Boehringer Ingelheim, Novartis, and Sanofi), academic and university medicine (Charité Berlin, Max Planck Society), and clinical diagnostics laboratories. Its go-to-market combines a self-serve digital platform (Atlas Portal) for direct sample submission and order creation with a partner laboratory network (Life & Brain, MDI Limbach Berlin) coordinated by Atlas Operator, and is supported by a technology ecosystem relationship with Thermo Fisher Scientific. The company claims 2,000+ customers served and 100,000+ samples processed cumulatively.

Atlas generates revenue through service-based laboratory fees for molecular analysis work, with quote-based enterprise pricing rather than publicly disclosed rate cards. The business model is a hybrid of direct enterprise lab services and a platform-mediated, routed distribution model that leverages partner lab capacity. Headcount is reported at 11–50 employees, and the company is privately held with no disclosed venture capital, private equity, or parent company ownership in the source data. The CEO is Paul Froutan. No funding rounds, acquisitions, regulatory actions, patents, or certifications were disclosed in the available material.

ATLAS Biolabs firmographics

Firmographics
Name
ATLAS Biolabs
Legal name
Atlas Life Sciences GmbH
Website
https://atlas-biolabs.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
ATLAS Biolabs is a Berlin-based molecular diagnostics infrastructure company offering an integrated platform (Atlas OS) that combines digital order management, automated laboratory routing, wet-lab processing, and bioinformatics to serve global pharmaceutical, academic research, and clinical diagnostics customers with genomic and multi-omics analysis services.
Ownership category
akta.pro rank

ATLAS Biolabs industry classification

Industry
Product category
Molecular Diagnostics Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • Molecular diagnostics services
  • Next-generation sequencing
  • Bioinformatics analysis
  • Pharmacogenomics testing
  • Genome analysis

Where ATLAS Biolabs is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

ATLAS Biolabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Molecular Diagnostics Laboratory Services: Atlas provides molecular analysis services including NGS, molecular karyotyping, epigenomics, pharmacogenomics, and proteomics. Revenue is generated through laboratory service fees charged to pharma, research, and clinical diagnostic customers. The platform routes orders to internal or partner laboratories under standardized operational protocols.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

ATLAS Biolabs product offering

Product offering

Core offering

ATLAS Biolabs operates a molecular diagnostics infrastructure combining wet-lab processing, bioinformatics, and digital workflow software. The company provides next-generation sequencing, molecular karyotyping, epigenomics, pharmacogenomics, and proteomics services routed through the Atlas OS platform, which integrates digital order management, automated laboratory assignment, sequencing/array processing, and structured report delivery. Services are delivered to enterprise customers in pharmaceutical, clinical diagnostics, and academic research sectors under standardized operational protocols.

Product overview

ATLAS Biolabs offers a unified platform-plus-modules architecture built around Atlas OS, an operational system for molecular diagnostics. The platform integrates multiple components: Atlas Portal (customer-facing interface for orders and results), Atlas Operator (automated routing), Atlas Lab (wet lab processing), and Atlas Bioinformatics (analysis and interpretation). These modules work together as an end-to-end operational system spanning sample intake, laboratory assignment, execution, review, and delivery. The service portfolio includes Next-Generation Sequencing (whole genome, exome, panels, amplicons), Molecular Karyotyping (CytoScan-based CNV/LOH detection), Epigenomics & Methylation profiling, Pharmacogenomics for medication optimization, and Proteomics & Multi-Omics. Atlas Protocol serves as a discovery platform for exploring diagnostic protocols.

Differentiator

Problem solved

Functional benefit

Products and services

  • Atlas OS Operational system layer beneath molecular diagnostics that integrates software, laboratory workflows, and structured data delivery into a single layer for intake, routing, analysis, and delivery across laboratories, clinics, and care networks.
  • Atlas Portal Customer-facing digital platform for sample intake, order creation, digital consent capture, sample metadata management, service selection, and structured result delivery. Reports are tracked, versioned, and available alongside the original order record.
  • Atlas Protocol Discovery platform for exploring and understanding Atlas Biolabs' diagnostic protocols and services.
  • Next-Generation Sequencing (NGS) Whole genome, whole exome, targeted panels, and amplicon sequencing services run under standardized operational standards across established and emerging platforms, for pharma, research, and clinical diagnostics customers.
  • Molecular Karyotyping CytoScan-based genome-wide copy number variation (CNV) and loss of heterozygosity (LOH) detection for molecular cytogenetic analysis.
  • Epigenomics & Methylation Genome-wide and targeted methylation profiling services for epigenetic analysis.
  • Pharmacogenomics (PGx) Preemptive pharmacogenomic profiling for medication optimization, enabling personalized drug selection based on genetic makeup.
  • Proteomics & Multi-Omics Protein-level analysis integrated with genomic data for comprehensive multi-omics profiling.
  • Bioinformatics Services Custom pipelines, variant calling, quality control, and interpretation services for molecular diagnostics results, preparing them for structured and auditable delivery.

Companies that use ATLAS Biolabs

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

ATLAS Biolabs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

ATLAS Biolabs partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Thermo Fisher ScientificcoreTechnology or IntegrationThermo Fisher Scientific is featured in Atlas's ecosystem as a selected relationship in diagnostics infrastructure. The partnership provides Atlas access to established laboratory technology platforms for molecular diagnostics operations.
  • Life & BraincoreTechnology or IntegrationLife & Brain is listed as a partner laboratory in Atlas's diagnostics infrastructure ecosystem. The partnership enables routing of orders to Life & Brain facilities based on capacity and capability requirements under standardized Atlas operational rules.
  • MDI Limbach BerlincoreChannel Partner/ Reseller/ DistributorMDI Limbach Berlin is featured in Atlas's ecosystem as a selected relationship in diagnostics infrastructure. As a partner laboratory, orders are routed to MDI Limbach based on optimal laboratory assignment criteria including capacity and turnaround time.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

ATLAS Biolabs competitors and assessment

Company assessment

Direct peers

  • Macrogen: Korea-based global genomics services company providing NGS, Sanger sequencing, microarray, and bioinformatics to pharma, clinical, and research customers. Comparable across service mix, customer segments, and international delivery.
  • CeGaT: Tübingen-based genomics and multi-omics services provider offering NGS, panels, and bioinformatics for pharma, research, and clinical customers. Closest direct peer to Atlas given German base, similar service portfolio, and overlapping pharma and academic customer base.
  • Novogene: Leading global NGS services provider with whole genome, exome, transcriptomics, and epigenomics offerings for pharma and academic customers. Directly comparable on service catalog, customer segments, and global delivery model.

Broad incumbents

  • QIAGEN: Global leader in sample preparation, molecular diagnostics assays, and bioinformatics (including the N-of-One acquired assets). Comparable at the bioinformatics and molecular diagnostics intersection, though QIAGEN is a much larger broad incumbent with its own assay portfolio.
  • BGI Genomics: One of the largest global genomics services organizations, with broad NGS, reproductive health, and clinical diagnostics offerings. Comparable in services but vastly larger scale and geographic footprint.
  • NeoGenomics: US-based clinical oncology-focused molecular diagnostics and contract research services company. Comparable in clinical molecular diagnostics services and pharma CRO offerings, but at much larger scale and oncology-centric scope.
  • Thermo Fisher Scientific (Clinical NGS services): Atlas's named ecosystem partner and a global leader in sequencing instruments, NGS reagents, and clinical NGS services. Comparable at the molecular diagnostics infrastructure layer, though Thermo Fisher is a broad incumbent with much greater scale and instrument ownership.
  • Eurofins Genomics: Global genomics services arm of Eurofins Scientific, offering sequencing, genotyping, oligonucleotides, and bioinformatics at much larger scale. Comparable offering but as a much broader incumbent across many geographies and assay types.

Emerging players

  • MedGenome: India- and US-based genomics and molecular diagnostics services company focused on genetic testing, NGS panels, and pharmacogenomics. Comparable in molecular diagnostics services for clinical and research customers, though at a different scale and geographic focus.
  • Strand Life Sciences: India-based company combining clinical genomics diagnostics, bioinformatics software, and pharma biomarker services. Comparable across multi-omics analytics and pharma services, though with a different geographic and customer mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ATLAS Biolabs social profiles

Digital presence

ATLAS Biolabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ATLAS Biolabs leadership team

Management profile

Number of profiles

Profiles1 record

ATLAS Biolabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ATLAS Biolabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATLAS Biolabs

What does ATLAS Biolabs do?

ATLAS Biolabs operates a molecular diagnostics infrastructure combining wet-lab processing, bioinformatics, and digital workflow software. The company provides next-generation sequencing, molecular karyotyping, epigenomics, pharmacogenomics, and proteomics services routed through the Atlas OS platform, which integrates digital order management, automated laboratory assignment, sequencing/array processing, and structured report delivery. Services are delivered to enterprise customers in pharmaceutical, clinical diagnostics, and academic research sectors under standardized operational protocols.

Is ATLAS Biolabs a public or private company?

ATLAS Biolabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ATLAS Biolabs founded?

ATLAS Biolabs was founded in 2006. It employs 11 to 50 people.

Where is ATLAS Biolabs based?

ATLAS Biolabs is headquartered in Berlin, Germany, in the Europe region.

How does ATLAS Biolabs make money?

One revenue line is on record: molecular Diagnostics Laboratory Services.

Who are ATLAS Biolabs's main competitors?

Direct peers on record are Macrogen, CeGaT and Novogene. Broad incumbents are QIAGEN, BGI Genomics, NeoGenomics, Thermo Fisher Scientific (Clinical NGS services) and Eurofins Genomics. Emerging players are MedGenome and Strand Life Sciences.

Does ATLAS Biolabs have an API?

No public API is recorded for ATLAS Biolabs.

What industry is ATLAS Biolabs in?

ATLAS Biolabs's product category is Molecular Diagnostics Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales